← Back to front page
Europe · General news · Daily Mirror

Pharmacist 'cautions' Ozempic and Wegovy users if taking warfarin

Published by Daily Mirror · United Kingdom 19 min ago
There is no need to panic, but just be cautious, the pharmacist says(Image: Getty Images)
There is no need to panic, but just be cautious, the pharmacist says(Image: Getty Images) · Daily Mirror

Detailed summary

While there is no cause for concern, users may need to have more tests

A pharmacist has issued an important message to people taking Wegovy or Ozempic. Charlotte Parker-Lennox, prescribing pharmacist at LloydsPharmacy Online Doctor, has said that "caution" may be needed in some cases when it comes to what else you might be taking, but there is no cause for alarm.

Semaglutide is a medicine used to treat obesity (Wegovy) or manage type 2 diabetes (Ozempic) and is only available with a prescription, either through the NHS or privately. Ozempic is not licensed as a weight loss treatment.

The NHS website notes that some medicines, herbal remedies, and supplements may not mix well with semaglutide. This includes medication like warfarin, which is an anticoagulant - some people call these blood thinners - and is used to treat and prevent blood clots, including clots in the veins (deep vein thrombosis) and in the lungs (pulmonary embolism).

Charlotte Parker-Lennox said that if you are taking both, there is no need to panic. But she urged patients to have their blood tested for how quickly it clots.

She told the Mirror: “While warfarin and semaglutide are not inherently an unsafe combination, in practice there is caution around their being prescribed together. One reason is that semaglutide slows how quickly food leaves the stomach, which can affect how quickly medicines move through the digestive system.

“There is no major direct pharmacological interaction between the two medications, but patients taking both should have their blood tested for how quickly it clots – known as an International Normalised Ratio or INR – particularly when starting semaglutide or following a dose increase."

Parker-Lennox studied at King’s College London and previously worked supporting NHS 111, providing clinical advice, triage and medication management across a range of patient populations. The expert added: "Patients should inform their anticoagulation or warfarin clinic if they are taking semaglutide so that any INR changes can quickly be identified.

Thankfully, if…

En…

Opening of the article, excerpted from Daily Mirror. To read the rest, open the article on the publisher's site.

Read the full article on Daily Mirror Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.mirror.co.uk)

Also worth reading